{'fraction_non_alphanumeric': 0.014308426073131956, 'fraction_numerical': 0.0, 'mean_word_length': 6.325581395348837, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus

It is important for primary care physicians to recognise rheumatoid arthritis and systemic lupus erythematosus patients as high‐risk groups for atherosclerosis, requiring aggressive risk‐factor modification. Recent studies suggest that this increased risk is not explained by an excess of traditional risk factors, but rather appears to be related to underlying rheumatic disease activity. Moreover, there is emerging data that aggressive treatment with disease‐modifying agents may reduce the incidence of atherosclerosis in these conditions.